Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00152659 · ClinicalTrials.gov registry record
Developing Criteria for Cortical Resections
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 87
- Enrollment target
NCT00152659: Completed study, sponsored by University of Chicago.
NCT00152659 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00152659 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to study how disease processes like tumors or epilepsy spread in the brain.
Interventions
- PROCEDURE Tissue sample (procedure/screening)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 1998-09-01 |
| Est. Completion | 2022-11-14 |
What the finished NCT00152659 record still lists
NCT00152659 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Tissue sample (procedure/screening) is the first listed.
NCT00152659 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00152659 about?
NCT00152659 is a clinical study titled "Developing Criteria for Cortical Resections". The purpose of this study is to study how disease processes like tumors or epilepsy spread in the brain.
What is the current status of trial NCT00152659?
This trial is currently completed. The enrollment target is 87 participants. The study started on 1998-09-01. Estimated completion is 2022-11-14.
What interventions are being tested in trial NCT00152659?
The interventions under investigation include: Tissue sample (procedure/screening) (PROCEDURE).
Who is sponsoring clinical trial NCT00152659?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI